Special Update Meeting: The latest on cell replacement therapies for Parkinson's
A special patient-focused event is scheduled for Thursday 15 May 2025, offering a unique opportunity for participants to engage with researchers in this field. Cure Parkinson’s is supporting the next G-Force PD meeting, an international consortium dedicated to advancing cell replacement therapies for Parkinson’s. This...
Learn more
Ambroxol and Parkinson’s
ASPro-PD, or Ambroxol to Slow Progression in Parkinson’s, is a phase 3 clinical trial looking to assess whether ambroxol, a cough medicine, can slow or stop the progression of Parkinson’s motor symptoms. Contents About the study Led by Professor Anthony Schapira at University College London...
UDCA and Parkinson’s
The UP Study, or UDCA for Parkinson’s Study, was a phase 2 clinical trial which aimed to assess the safety and tolerability of ursodeoxycholic acid (UDCA) in people with Parkinson’s. Contents About the study Led by Professor Oliver Bandmann at the University of Sheffield, this...